Form 8-K - Current report:
SEC Accession No. 0000950170-25-110547
Filing Date
2025-08-21
Accepted
2025-08-21 06:15:50
Documents
10
Period of Report
2025-08-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neog-20250815.htm   iXBRL 8-K 65368
  Complete submission text file 0000950170-25-110547.txt   173910

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20250815.xsd EX-101.SCH 25023
12 EXTRACTED XBRL INSTANCE DOCUMENT neog-20250815_htm.xml XML 4730
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)